Author:
Kesler Mikhail,Cohen Dan,Levine Charles,Sarid David,Keizman Daniel,Yossepowitch Ofer,Even-Sapir Einat
Publisher
Society of Nuclear Medicine
Subject
Radiology, Nuclear Medicine and imaging
Reference21 articles.
1. 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer;Cytawa;Eur J Nucl Med Mol Imaging.,2020
2. Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
3. Diagnostic accuracy of 68Ga-PSMA PET/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis;Satapathy;AJR.,2021
4. FDA approves first PSMA-targeted PET imaging drug for men with prostate cancer. U.S. Food and Drug Administration website. https://www.fda.gov/news-events/press-announcements/fda-approves-first-psma-targeted-pet-imaging-drug-men-prostate-cancer. Published December 1, 2020. Accessed March 30, 2023.
5. Israel Ministry of Health – updates in the Israeli medical services basket [in Hebrew]. Israel Ministry of Health website. https://www.health.gov.il/hozer/mr02_2016.pdf. Published February 2016. Accessed March 30, 2023.